GentiBio H-1B Visa Sponsorship 2026
Research and Development in Biotechnology Β· H-1B sponsor Β· FY2017β2026
π’ Cambridge, MA HQπ gentibio.com
Does GentiBio sponsor H-1B visas?
Yes. GentiBio has filed 3 H-1B LCAs with the U.S. Department of Labor between FY2023 and FY2026. In FY2026 GentiBio filed 1 H-1B LCA. No PERM green-card cases are on record.
It files most often for Principal Scientist roles, most in Cambridge, MA.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 1 | $165k |
| FY2024 | 1 | $145k |
| FY2023 | 1 | $95k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
Where they hire
Worker backgrounds
From green-card (PERM) cases
Sponsors H-1B workers but has few or no green-card (PERM) cases under this name, so worker backgrounds arenβt available.
Pay against the local market
GentiBioβs most-filed occupations and metros, FY2024βFY2026. Its median base salary is 150% of the local BLS median for the same work.
| Occupation | Metro | Filings | GentiBio pay | Local BLS medianβ‘ | vs market |
|---|---|---|---|---|---|
| Biological Scientists, All Other | Boston, MA | 2 | $155,000 | $103,120 | 150% |
About GentiBio
- Name (DOL filings)
- GentiBio, Inc.
- Listed
- β
- Sponsoring since
- FY2023
- Main filing location
- Cambridge, MA
- Industry (NAICS)
- Research and Development in Biotechnology
- Website
- gentibio.com
- H-1B filings
- 3
- Median base
- $145,000
- R&D
- β
H-1B sponsors similar to GentiBio
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Adimab Service Company | 15 | 7 | $146k | 5 | β |
| Colossal Biosciences | 15 | 4 | $128k | 2 | β |
| Generation Bio Co. | 15 | 3 | $155k | 0 | β |
| Enveda Therapeutics | 14 | 6 | $184k | 2 | β |
| Hansoh Bio | 14 | 6 | $103k | 1 | β |
| Neuro42 | 14 | 4 | $124k | 2 | β |
| GentiBio | 3 | 1 | $165k | 0 | β |
